tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Atossa Therapeutics (DE:YAG2)
FRANKFURT:YAG2
Germany Market
YAG2
Atossa Therapeutics
Overview
Analyst Forecasts
News & Insights
Financials
Dividends
Technical Analysis
Chart
Earnings
Ownership
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Atossa Therapeutics (YAG2) Stock News & Sentiment

Compare
2 Followers
Positive Buy Rating for Atossa Therapeutics Driven by Promising Z-endoxifen Efficacy in Breast Cancer
Premium
Ratings
Positive Buy Rating for Atossa Therapeutics Driven by Promising Z-endoxifen Efficacy in Breast Cancer
9h ago
ATOS
Atossa Therapeutics: Q3 2024 Financial Results and Updates
Premium
Company Announcements
Atossa Therapeutics: Q3 2024 Financial Results and Updates
4M ago
ATOS
Atossa Therapeutics, Inc. (ATOS) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Atossa Therapeutics, Inc. (ATOS) Q3 Earnings Cheat Sheet
4M ago
ATOS
Atos Shares Drop on Reduced Financial Targets
Premium
Market News
Atos Shares Drop on Reduced Financial Targets
6M ago
ATOS
Navigating Choppy Waters: Atossa Therapeutics’ Struggle with Compliance Costs and Business Performance
Premium
Company Announcements
Navigating Choppy Waters: Atossa Therapeutics’ Struggle with Compliance Costs and Business Performance
11M ago
ATOS
Is ATOS a Buy, Before Earnings?
Premium
Pre-Earnings
Is ATOS a Buy, Before Earnings?
12M ago
ATOS
Atossa Therapeutics Appoints Dr. Cigler, Expands Board Governance
Premium
Company Announcements
Atossa Therapeutics Appoints Dr. Cigler, Expands Board Governance
1y ago
8K
ATOS
More DE:YAG2 News >

YAG2 News on the Web

Atossa Therapeutics Announces Plans to Pursue Metastatic Breast Cancer Indication for -Endoxifen and Continued Engagement with FDA on Additional Indications
Yahoo Finance
Neutral
Atossa Therapeutics Congratulates Board Director Dr. Tessa Cigler and Weill Cornell Medicine on CDC Grant to Enhance Breast Cancer Care
Yahoo Finance
Neutral
Atossa Therapeutics Issues Letter to Shareholders Highlighting 2024 Accomplishments and Outlook for 2025
Yahoo Finance
Neutral
TCMD Stock Rises 20% in Three Months: Should You Buy, Hold or Sell?
Zacks
Neutral
Is Atossa Genetics (ATOS) Stock Outpacing Its Medical Peers This Year?
Zacks
Neutral
Atossa Therapeutics’ Promising EVANGELINE Study and Strong Buy Rating from Analyst Jason McCarthy
TipRanks News
Bullish
Is Intuitive Surgical (ISRG) Outperforming Other Medical Stocks This Year?
Zacks
Neutral
Atossa Therapeutics: Promising Oncology Asset and Strong Financial Position Justify Buy Rating
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
DE:YAG2
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average54%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:YAG2’s Media Buzz Sentiment?
1 articles about DE:YAG2 were published this week. In an average week, 1 articles are published.
    What is DE:YAG2’s weekly average amount of articles?
    In an average week, 1 articles about DE:YAG2 are published.
      What is DE:YAG2’s News Sentiment?
      50% of articles about DE:YAG2 were positive this week, compared to its sector average of 54%.
        Healthcare Stocks that are Trending in the News
        PTGXProtagonist Therapeutics
        FENCFennec Pharmaceuticals
        CKPTCheckpoint Therapeutics
        CSBTFKuros Biosciences
        MDPediatrix Medical Group
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing